1 Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial The Lancet Oncology, June 11, 2013
2 Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial The Lancet, May 31, 2013 Evidence Based Medicine
3 Effect of preemptive and preventive acetaminophen on postoperative pain score: a randomized, double-blind trial of patients undergoing lower extremity surgery Journal of Clinical Anesthesia, May 22, 2013
4
Panitumumab and irinotecan versus irinotecan alone for patients with wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial
The Lancet Oncology, May 31, 2013
Exclusive Author Commentary
5 Telomere length and risk of melanoma, squamous cell carcinoma, and basal cell carcinoma Cancer Epidemiology, June 17, 2013
6 Ultraviolet index and racial differences in prostate cancer incidence and mortality Cancer, June 10, 2013
7 Efficacy and safety of Huachansu combined with chemotherapy in advanced gastric cancer: A meta-analysis Medical Hypotheses, May 23, 2013 Evidence Based Medicine
8 Bronchial hyperresponsiveness in pediatric rhinitis patients: The difference between allergic and nonallergic rhinitis The American Journal of Rhinology & Allergy, May 28, 2013
9 Efficacy and Safety of Whole Body Skin Cleansing With Chlorhexidine in Neonates—A Systemic Review The Pediatric Infectious Disease Journal, May 20, 2013 Evidence Based Medicine
10 Moh's surgery in metastatic cancer: renal cell carcinoma solitary cutaneous metastasis and visceral tumor metastases to skin treated with microscopically controlled surgical excision International Journal of Dermatology, May 22, 2013
Sponsor
Register now to view all the MDLinx contents (FREE)!
Login
Sponsor
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close
Sponsor